1. A phase 1 study of cetuximab and lapatinib in patients with advanced solid tumor malignancies. Issue 10 (29th January 2015) Authors: Deeken, John F.; Wang, Hongkun; Subramaniam, Deepa; He, Aiwu Ruth; Hwang, Jimmy; Marshall, John L.; Urso, Christina E.; Wang, Yiru; Ramos, Corinne; Steadman, Kenneth; Pishvaian, Michael J. Journal: Cancer Issue: Volume 121:Issue 10(2015) Page Start: 1645 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Addition of ramucirumab or merestinib to standard first-line chemotherapy for locally advanced or metastatic biliary tract cancer: a randomised, double-blind, multicentre, phase 2 study. Issue 10 (October 2021) Authors: Valle, Juan W; Vogel, Arndt; Denlinger, Crystal S; He, Aiwu Ruth; Bai, Li-Yuan; Orlova, Rashida; Van Cutsem, Eric; Adeva, Jorge; Chen, Li-Tzong; Obermannova, Radka; Ettrich, Thomas J; Chen, Jen-Shi; Wasan, Harpreet; Girvan, Allicia C; Zhang, Wei; Liu, Jiangang; Tang, Chunlao; Ebert, Philip J; Agg... Journal: Lancet oncology Issue: Volume 22:Issue 10(2021) Page Start: 1468 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. An endogenous DNA adduct as a prognostic biomarker for hepatocarcinogenesis and its prevention by Theaphenon E in mice. Issue 1 (13th November 2017) Authors: Fu, Ying; Silverstein, Shana; McCutcheon, Justine N.; Dyba, Marcin; Nath, Raghu G.; Aggarwal, Monika; Coia, Heidi; Bai, Angela; Pan, Jishen; Jiang, Jiji; Kallakury, Bhaskar; Wang, Hongkun; Zhang, Yu‐Wen; Giaccone, Giuseppe; He, Aiwu Ruth; Chung, Fung‐Lung Journal: Hepatology Issue: Volume 67:Issue 1(2018) Page Start: 159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b study. Issue 6 (June 2020) Authors: Lee, Michael S; Ryoo, Baek-Yeol; Hsu, Chih-Hung; Numata, Kazushi; Stein, Stacey; Verret, Wendy; Hack, Stephen P; Spahn, Jessica; Liu, Bo; Abdullah, Heba; Wang, Yulei; He, Aiwu Ruth; Lee, Kyung-Hun Journal: Lancet oncology Issue: Volume 21:Issue 6(2020) Page Start: 808 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Bridging and downstaging with TACE in early and intermediate stage hepatocellular carcinoma: Predictors of receiving a liver transplant. Issue 2 (24th November 2022) Authors: Yin, Chao; Armstrong, Samantha; Shin, Richard; Geng, Xue; Wang, Hongkun; Satoskar, Rohit S.; Fishbein, Thomas; Smith, Coleman; Banovac, Filip; Kim, Alexander Y.; He, Aiwu Ruth Journal: Annals of gastroenterological surgery Issue: Volume 7:Issue 2(2023) Page Start: 295 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. First‐in‐Human Phase I Study of Merestinib, an Oral Multikinase Inhibitor, in Patients with Advanced Cancer. (4th March 2019) Authors: He, Aiwu Ruth; Cohen, Roger B.; Denlinger, Crystal S.; Sama, Ashwin; Birnbaum, Ariel; Hwang, Jimmy; Sato, Takami; Lewis, Nancy; Mynderse, Michelle; Niland, Michele; Giles, Jennifer; Wallin, Johan; Moser, Brian; Zhang, Wei; Walgren, Richard; Plimack, Elizabeth R. Journal: Oncologist Issue: Volume 24:Number 9(2019) Page Start: e930 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Liver Cancer Stem Cells. (11th May 2011) Authors: Mikhail, Sameh; He, Aiwu Ruth Other Names: Chow Pierce Academic Editor. Journal: International journal of hepatology Issue: Volume 2011(2011) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Nivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial. Issue 9 (20th March 2023) Authors: Yau, Thomas; Zagonel, Vittorina; Santoro, Armando; Acosta-Rivera, Mirelis; Choo, Su Pin; Matilla, Ana; He, Aiwu Ruth; Cubillo Gracian, Antonio; El-Khoueiry, Anthony B.; Sangro, Bruno; Eldawy, Tarek E.; Bruix, Jordi; Frassineti, Giovanni Luca; Vaccaro, Gina M.; Tschaika, Marina; Scheffold, Christi... Journal: Journal of clinical oncology Issue: Volume 41:Issue 9(2023) Page Start: 1747 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Novel low‐avidity glypican‐3 specific CARTs resist exhaustion and mediate durable antitumor effects against HCC. Issue 2 (27th December 2021) Authors: Caraballo Galva, Leidy D.; Jiang, Xiaotao; Hussein, Mohamed S.; Zhang, Huajun; Mao, Rui; Brody, Pierce; Peng, Yibing; He, Aiwu Ruth; Kehinde‐Ige, Mercy; Sadek, Ramses; Qiu, Xiangguo; Shi, Huidong; He, Yukai Journal: Hepatology Issue: Volume 76:Issue 2(2022) Page Start: 330 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Phase 2, multicenter, open‐label study of tigatuzumab (CS‐1008), a humanized monoclonal antibody targeting death receptor 5, in combination with gemcitabine in chemotherapy‐naive patients with unresectable or metastatic pancreatic cancer. (25th October 2013) Authors: Forero‐Torres, Andres; Infante, Jeffrey R.; Waterhouse, David; Wong, Lucas; Vickers, Selwyn; Arrowsmith, Edward; He, Aiwu Ruth; Hart, Lowell; Trent, David; Wade, James; Jin, Xiaoping; Wang, Qiang; Austin, TaShara; Rosen, Michael; Beckman, Robert; von, Reinhard; Greenberg, Jonathan; Saleh, Mansoor Journal: Cancer medicine Issue: Volume 2:Number 6(2013:Dec.) Page Start: 925 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗